Literature DB >> 10490448

Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?

A Koziell1, R Grundy.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10490448      PMCID： PMC1718089          DOI： 10.1136/adc.81.4.365

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  40 in total

1.  Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.

Authors:  J F Morris; S L Madden; O E Tournay; D M Cook; V P Sukhatme; F J Rauscher
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

2.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

3.  The candidate Wilms' tumour gene is involved in genitourinary development.

Authors:  K Pritchard-Jones; S Fleming; D Davidson; W Bickmore; D Porteous; C Gosden; J Bard; A Buckler; J Pelletier; D Housman
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

Review 4.  The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.

Authors:  F J Rauscher
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

Review 5.  The role of WT1 in Wilms tumorigenesis.

Authors:  M J Coppes; C E Campbell; B R Williams
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

6.  Extended followup of bilateral Wilms tumor: results of the National Wilms Tumor Study.

Authors:  B T Montgomery; P P Kelalis; M L Blute; E J Bergstralh; J B Beckwith; P Norkool; D M Green; G J D'Angio
Journal:  J Urol       Date:  1991-08       Impact factor: 7.450

7.  Alternative splicing and genomic structure of the Wilms tumor gene WT1.

Authors:  D A Haber; R L Sohn; A J Buckler; J Pelletier; K M Call; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

8.  The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

Authors:  J F Armstrong; K Pritchard-Jones; W A Bickmore; N D Hastie; J B Bard
Journal:  Mech Dev       Date:  1993-01       Impact factor: 1.882

Review 9.  Precursor lesions of Wilms tumor: clinical and biological implications.

Authors:  J B Beckwith
Journal:  Med Pediatr Oncol       Date:  1993

10.  Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.

Authors:  M H Little; K A Williamson; M Mannens; A Kelsey; C Gosden; N D Hastie; V van Heyningen
Journal:  Hum Mol Genet       Date:  1993-03       Impact factor: 6.150
View more
  5 in total

1.  Suspicion of Frasier's Syndrome in the Nephrology Unit of the State University Hospital of Haiti: Case Study and Review of Literature.

Authors:  Axler Jean Paul; Dieuguens Louis; Ansly Jefferson Desravines; Raema Mimrod Jean; Alfadler Jean Baptiste; Jean Henold Buteau; Wislet Andre
Journal:  Int Med Case Rep J       Date:  2021-08-12

2.  Case report: Denys- Drash syndrome.

Authors:  A B Ammari; D E Fung
Journal:  Eur Arch Paediatr Dent       Date:  2007-12

3.  Denys-Drash syndrome associated WT1 glutamine 369 mutants have altered sequence-preferences and altered responses to epigenetic modifications.

Authors:  Hideharu Hashimoto; Xing Zhang; Yu Zheng; Geoffrey G Wilson; Xiaodong Cheng
Journal:  Nucleic Acids Res       Date:  2016-09-04       Impact factor: 16.971

Review 4.  WT1 complete gonadal dysgenesis with membranoproliferative glomerulonephritis: case series and literature review.

Authors:  Erin Anderson; Melanie Aldridge; Ross Turner; James Harraway; Sam McManus; Anna Stewart; Peter Borzi; Peter Trnka; John Burke; David Coman
Journal:  Pediatr Nephrol       Date:  2022-02-24       Impact factor: 3.651

5.  Diffuse mesangial sclerosis - Report of two cases.

Authors:  M Vankalakunti; P K Jha; R M Madraki; V Siddini; K Babu; S H Ballal
Journal:  Indian J Nephrol       Date:  2012-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.